INTRODUCTION: Blunt cerebrovascular injuries (BCVI) of the extra- or intracerebral vessels are frequently observed lesions which may lead to thrombembolic events with focal neurological deficits, stroke or death particularly in patients <60 years. However, a comprehensive standardised clinical algorithm for screening and management of these secondary injuries is still lacking. MATERIALS AND METHODS: We developed a standardised screening protocol applicable for mild as well as severely injured patients. In this prospective cohort study, we evaluated the feasibility of this diagnostic algorithm in a level 1 trauma centre setting. Trauma patients who met the inclusion criteria underwent a computed tomographic angiography (CTA) as part of standard diagnostic procedure at admission. All suspicions or positive findings were reevaluated by a conventional four-vessel catheter angiography within the first 72 h after trauma. Within this period, anticoagulation with low-dose heparin was started. BCVI confirmation indicated a shift to systemic heparinisation with overlapping phenprocoumon therapy for at least 6 months. All patients were reevaluated after 6 months by another four-vessel angiography. Depending on the diagnostic findings, oral anticoagulation may be discontinued or continued for another 6 months. RESULTS: A total of 44 patients (8 male, 6 female, age range 19-95 years) were included in the study. 20 BCVIs were detected in 16 patients (36.3%). The most common injuries identified were Biffl Type II (40%) and Type IV lesions (30%). 86.4% of the patients received a CTA upon admission, 93.2% of which were conducted within 12 h posttrauma. None of the patients had a secondary thrombembolic neurological event during the hospital stay or within 3 months postdischarge. CONCLUSION: Our results indicate that implementation of the screening protocol can prevent strokes in patients without primary thrombembolic neurological deficits.
INTRODUCTION: Blunt cerebrovascular injuries (BCVI) of the extra- or intracerebral vessels are frequently observed lesions which may lead to thrombembolic events with focal neurological deficits, stroke or death particularly in patients <60 years. However, a comprehensive standardised clinical algorithm for screening and management of these secondary injuries is still lacking. MATERIALS AND METHODS: We developed a standardised screening protocol applicable for mild as well as severely injured patients. In this prospective cohort study, we evaluated the feasibility of this diagnostic algorithm in a level 1 trauma centre setting. Traumapatients who met the inclusion criteria underwent a computed tomographic angiography (CTA) as part of standard diagnostic procedure at admission. All suspicions or positive findings were reevaluated by a conventional four-vessel catheter angiography within the first 72 h after trauma. Within this period, anticoagulation with low-dose heparin was started. BCVI confirmation indicated a shift to systemic heparinisation with overlapping phenprocoumon therapy for at least 6 months. All patients were reevaluated after 6 months by another four-vessel angiography. Depending on the diagnostic findings, oral anticoagulation may be discontinued or continued for another 6 months. RESULTS: A total of 44 patients (8 male, 6 female, age range 19-95 years) were included in the study. 20 BCVIs were detected in 16 patients (36.3%). The most common injuries identified were Biffl Type II (40%) and Type IV lesions (30%). 86.4% of the patients received a CTA upon admission, 93.2% of which were conducted within 12 h posttrauma. None of the patients had a secondary thrombembolic neurological event during the hospital stay or within 3 months postdischarge. CONCLUSION: Our results indicate that implementation of the screening protocol can prevent strokes in patients without primary thrombembolic neurological deficits.
Authors: Garth H Utter; William Hollingworth; Danial K Hallam; Jeffrey G Jarvik; Gregory J Jurkovich Journal: J Am Coll Surg Date: 2006-10-04 Impact factor: 6.113
Authors: Walter L Biffl; Charles E Ray; Ernest E Moore; Reginald J Franciose; Somer Aly; Mary Grace Heyrosa; Jeffrey L Johnson; Jon M Burch Journal: Ann Surg Date: 2002-05 Impact factor: 12.969
Authors: Jeffrey David Lewine; John T Davis; Erin D Bigler; Robert Thoma; Dina Hill; Michael Funke; John Henry Sloan; Sandra Hall; William W Orrison Journal: J Head Trauma Rehabil Date: 2007 May-Jun Impact factor: 2.710
Authors: Ole Risgaard; Michael Sugrue; Scott D'Amours; Grant Christey; Katherine Smith; Erica Caldwell; Christian Larivière Journal: ANZ J Surg Date: 2007-08 Impact factor: 1.872
Authors: Preston R Miller; Timothy C Fabian; Martin A Croce; Catherine Cagiannos; J Scott Williams; Meng Vang; Waleed G Qaisi; Richard E Felker; Shelly D Timmons Journal: Ann Surg Date: 2002-09 Impact factor: 12.969
Authors: Megan M Lockwood; Gabriel A Smith; Joseph Tanenbaum; Daniel Lubelski; Andreea Seicean; Jonathan Pace; Edward C Benzel; Thomas E Mroz; Michael P Steinmetz Journal: J Neurosurg Spine Date: 2015-11-27
Authors: Peter B Sporns; Thomas Niederstadt; Walter Heindel; Michael J Raschke; René Hartensuer; Ralf Dittrich; Uta Hanning Journal: Clin Neuroradiol Date: 2018-01-26 Impact factor: 3.649